Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency

Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of allergy and clinical immunology in practice (Cambridge, MA) MA), 2023-03, Vol.11 (3), p.963-965.e1
Hauptverfasser: Suffritti, Chiara, Sartorio, Silvio, Berra, Silvia, Janu, Valentina Popescu, Caccia, Sonia, Zanichelli, Andrea
Format: Artikel
Sprache:eng
Schlagworte:
Angioedema - drug therapy
Angioedemas, Hereditary - drug therapy
Antibodies, Monoclonal, Humanized - therapeutic use
Complement C1 Inactivator Proteins
Complement C1 Inhibitor Protein - therapeutic use
Humans
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 965.e1
container_issue 3
container_start_page 963
container_title The journal of allergy and clinical immunology in practice (Cambridge, MA)
container_volume 11
creator Suffritti, Chiara
Sartorio, Silvio
Berra, Silvia
Janu, Valentina Popescu
Caccia, Sonia
Zanichelli, Andrea
description
doi_str_mv 10.1016/j.jaip.2022.10.041
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2737119238</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2213219822011862</els_id><sourcerecordid>2737119238</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-84b4a12559128a0f57c73e4d22d293e6f8e71e105767db1ef70429d917583cda3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMottT-AQ-So5fWTLK72QUvUuoHVLzoOWSTiabsR7vZFfrvTW3r0blkGJ55yTyEXAObA4Psbj1fa7-Zc8Z5HMxZAmdkzDmIGecMzk89FPmITENYs1g5SJawSzISmZBFAmxMXpfOeaPNjraOVrrRFquh1iX1DdXNp2_RYq2pHZD2LdVmO_gOLV1ABL586fu2oxZjhMfG7K7IhdNVwOnxnZCPx-X74nm2ent6WTysZkakWT_LkzLRwNO0AJ5r5lJppMDEcm55ITBzOUpAYKnMpC0BXfw2L2wBMs2FsVpMyO0hd9O12wFDr2ofDFbxAGyHoLgUEqDgIo8oP6Cma0Po0KlN52vd7RQwtTep1mpvUu1N7mfRZFy6OeYPZY32b-XkLQL3BwDjld8eOxV-DaCNekyvbOv_y_8BA4yClw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2737119238</pqid></control><display><type>article</type><title>Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Suffritti, Chiara ; Sartorio, Silvio ; Berra, Silvia ; Janu, Valentina Popescu ; Caccia, Sonia ; Zanichelli, Andrea</creator><creatorcontrib>Suffritti, Chiara ; Sartorio, Silvio ; Berra, Silvia ; Janu, Valentina Popescu ; Caccia, Sonia ; Zanichelli, Andrea</creatorcontrib><identifier>ISSN: 2213-2198</identifier><identifier>EISSN: 2213-2201</identifier><identifier>DOI: 10.1016/j.jaip.2022.10.041</identifier><identifier>PMID: 36379410</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Angioedema - drug therapy ; Angioedemas, Hereditary - drug therapy ; Antibodies, Monoclonal, Humanized - therapeutic use ; Complement C1 Inactivator Proteins ; Complement C1 Inhibitor Protein - therapeutic use ; Humans</subject><ispartof>The journal of allergy and clinical immunology in practice (Cambridge, MA), 2023-03, Vol.11 (3), p.963-965.e1</ispartof><rights>2022 American Academy of Allergy, Asthma &amp; Immunology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-84b4a12559128a0f57c73e4d22d293e6f8e71e105767db1ef70429d917583cda3</citedby><cites>FETCH-LOGICAL-c356t-84b4a12559128a0f57c73e4d22d293e6f8e71e105767db1ef70429d917583cda3</cites><orcidid>0000-0002-8872-8842</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27933,27934</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36379410$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suffritti, Chiara</creatorcontrib><creatorcontrib>Sartorio, Silvio</creatorcontrib><creatorcontrib>Berra, Silvia</creatorcontrib><creatorcontrib>Janu, Valentina Popescu</creatorcontrib><creatorcontrib>Caccia, Sonia</creatorcontrib><creatorcontrib>Zanichelli, Andrea</creatorcontrib><title>Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency</title><title>The journal of allergy and clinical immunology in practice (Cambridge, MA)</title><addtitle>J Allergy Clin Immunol Pract</addtitle><subject>Angioedema - drug therapy</subject><subject>Angioedemas, Hereditary - drug therapy</subject><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>Complement C1 Inactivator Proteins</subject><subject>Complement C1 Inhibitor Protein - therapeutic use</subject><subject>Humans</subject><issn>2213-2198</issn><issn>2213-2201</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMottT-AQ-So5fWTLK72QUvUuoHVLzoOWSTiabsR7vZFfrvTW3r0blkGJ55yTyEXAObA4Psbj1fa7-Zc8Z5HMxZAmdkzDmIGecMzk89FPmITENYs1g5SJawSzISmZBFAmxMXpfOeaPNjraOVrrRFquh1iX1DdXNp2_RYq2pHZD2LdVmO_gOLV1ABL586fu2oxZjhMfG7K7IhdNVwOnxnZCPx-X74nm2ent6WTysZkakWT_LkzLRwNO0AJ5r5lJppMDEcm55ITBzOUpAYKnMpC0BXfw2L2wBMs2FsVpMyO0hd9O12wFDr2ofDFbxAGyHoLgUEqDgIo8oP6Cma0Po0KlN52vd7RQwtTep1mpvUu1N7mfRZFy6OeYPZY32b-XkLQL3BwDjld8eOxV-DaCNekyvbOv_y_8BA4yClw</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Suffritti, Chiara</creator><creator>Sartorio, Silvio</creator><creator>Berra, Silvia</creator><creator>Janu, Valentina Popescu</creator><creator>Caccia, Sonia</creator><creator>Zanichelli, Andrea</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8872-8842</orcidid></search><sort><creationdate>202303</creationdate><title>Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency</title><author>Suffritti, Chiara ; Sartorio, Silvio ; Berra, Silvia ; Janu, Valentina Popescu ; Caccia, Sonia ; Zanichelli, Andrea</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-84b4a12559128a0f57c73e4d22d293e6f8e71e105767db1ef70429d917583cda3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Angioedema - drug therapy</topic><topic>Angioedemas, Hereditary - drug therapy</topic><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>Complement C1 Inactivator Proteins</topic><topic>Complement C1 Inhibitor Protein - therapeutic use</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suffritti, Chiara</creatorcontrib><creatorcontrib>Sartorio, Silvio</creatorcontrib><creatorcontrib>Berra, Silvia</creatorcontrib><creatorcontrib>Janu, Valentina Popescu</creatorcontrib><creatorcontrib>Caccia, Sonia</creatorcontrib><creatorcontrib>Zanichelli, Andrea</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of allergy and clinical immunology in practice (Cambridge, MA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suffritti, Chiara</au><au>Sartorio, Silvio</au><au>Berra, Silvia</au><au>Janu, Valentina Popescu</au><au>Caccia, Sonia</au><au>Zanichelli, Andrea</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency</atitle><jtitle>The journal of allergy and clinical immunology in practice (Cambridge, MA)</jtitle><addtitle>J Allergy Clin Immunol Pract</addtitle><date>2023-03</date><risdate>2023</risdate><volume>11</volume><issue>3</issue><spage>963</spage><epage>965.e1</epage><pages>963-965.e1</pages><issn>2213-2198</issn><eissn>2213-2201</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36379410</pmid><doi>10.1016/j.jaip.2022.10.041</doi><orcidid>https://orcid.org/0000-0002-8872-8842</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2213-2198
ispartof The journal of allergy and clinical immunology in practice (Cambridge, MA), 2023-03, Vol.11 (3), p.963-965.e1
issn 2213-2198
2213-2201
language eng
recordid cdi_proquest_miscellaneous_2737119238
source MEDLINE; Alma/SFX Local Collection
subjects Angioedema - drug therapy
Angioedemas, Hereditary - drug therapy
Antibodies, Monoclonal, Humanized - therapeutic use
Complement C1 Inactivator Proteins
Complement C1 Inhibitor Protein - therapeutic use
Humans
title Efficacy of lanadelumab in angioedema due to acquired C1 inhibitor deficiency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T06%3A49%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20lanadelumab%20in%20angioedema%20due%20to%20acquired%20C1%20inhibitor%20deficiency&rft.jtitle=The%20journal%20of%20allergy%20and%20clinical%20immunology%20in%20practice%20(Cambridge,%20MA)&rft.au=Suffritti,%20Chiara&rft.date=2023-03&rft.volume=11&rft.issue=3&rft.spage=963&rft.epage=965.e1&rft.pages=963-965.e1&rft.issn=2213-2198&rft.eissn=2213-2201&rft_id=info:doi/10.1016/j.jaip.2022.10.041&rft_dat=%3Cproquest_cross%3E2737119238%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2737119238&rft_id=info:pmid/36379410&rft_els_id=S2213219822011862&rfr_iscdi=true